Poster presented at ASH 2016
Modus Therapeutics presented poster at 58th ASH Annual Meeting in San Diego in December 2016.

The paper was entitled ‘Sevuparin blocks sickle blood cell adhesion and sickle leukocyte rolling on immobilized L-selectin in a dose-dependent manner’

View PDF